TY - JOUR A1 - Heyn, Jens Michael A1 - Bräuninger, Susanne Barbara A1 - Dimova-Dobreva, Miryana A1 - Mathieson, Nicola A1 - Koptelova, Natalia V. A1 - Kolpakova, Anna A1 - Seidl, Christian A1 - Reinhardt, Peter A1 - Tsamadou, Chrysanthi A1 - Schrezenmeier, Hubert A1 - Nakov, Roumen A1 - Seifried, Erhard A1 - Bönig, Halvard-Björn T1 - Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation T2 - Journal of translational medicine N2 - Background: Safety, tolerability and efficacy of granulocyte colony-stimulating factor (G-CSF) for mobilization of hematopoietic stem and progenitor cells (HSPCs) from healthy donors have been conclusively demonstrated. This explicitly includes, albeit for smaller cohorts and shorter observation periods, biosimilar G-CSFs. HSPC donation is non-remunerated, its sole reward being “warm glow”, hence harm to donors must be avoided with maximal certitude. To ascertain, therefore, long-term physical and mental health effects of HSPC donation, a cohort of G-CSF mobilized donors was followed longitudinally. Methods: We enrolled 245 healthy volunteers in this bi-centric long-term surveillance study. 244 healthy volunteers began mobilization with twice-daily Sandoz biosimilar filgrastim and 242 underwent apheresis after G-CSF mobilization. Physical and mental health were followed up over a period of 5-years using the validated SF-12 health questionnaire. Results: Baseline physical and mental health of HSPC donors was markedly better than in a healthy reference population matched for ethnicity, sex and age. Physical, but not mental health was sharply diminished at the time of apheresis, likely due to side effects of biosimilar G-CSF, however had returned to pre-apheresis values by the next follow-up appointment after 6 months. Physical and mental health slightly deteriorated over time with kinetics reflecting the known effects of aging. Hence, superior physical and mental health compared to the general healthy non-donor population was maintained over time. Conclusions: HSPC donors are of better overall physical and mental health than the average healthy non-donor. Superior well-being is maintained over time, supporting the favorable risk–benefit assessment of volunteer HSPC donation. Trial registration National Clinical Trial NCT01766934 KW - Healthy stem cell donors KW - Filgrastim KW - Physical and mental health KW - SF-12 Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/69509 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-695091 SN - 1479-5876 N1 - Open Access funding enabled and organized by Projekt DEAL. N1 - This study is funded by Sandoz biopharmaceuticals/Hexal AG. VL - 20 IS - art. 121 SP - 1 EP - 8 PB - BioMed Central CY - London ER -